Lenner P, Jonsson H
Department of Oncology, Umeå University Hospital, Sweden.
J Med Screen. 1997;4(1):6-9. doi: 10.1177/096914139700400104.
Previous randomised studies of mammography screening have shown a significant effect on breast cancer mortality, particularly in women aged 50-69 at randomisation. Breast cancer mortality has traditionally been studied by judgments on causes of death, either from cause of death registers or from medical records. In this study an alternative method was used, estimating the excess mortality associated with breast cancer.
In 1990 two counties of northern Sweden started population based mammography screening of women aged 40-74. The unscreened population in the two other counties of the same region were selected as controls.
Excess mortality associated with breast cancer was lower in the screened population, and was discernible three to four years after the start of screening. The relative risk estimate, based on the cumulative excess number of deaths from breast cancer during 1990-95 in the screened versus the control population aged 40-74 (at diagnosis of breast cancer), was 0.72 (95% confidence interval (CI) 0.53 to 0.99). For women aged 50-69 it was 0.67 (95% CI 0.46 to 0.99). In the 50-69 age group the estimated excess number of deaths from breast cancer during 1995 was 17.0 per 100,000 women (95% CI 5.0 to 29.0) in the screened counties and 51.1 per 100,000 (95% CI 30.2 to 71.9) in the unscreened counties.
Population based routine screening has substantial effects on breast cancer mortality in women aged 50-69. Estimation of excess mortality can be used in future studies to evaluate the effects of mammography screening on breast cancer mortality.
以往关于乳腺钼靶筛查的随机研究表明,其对乳腺癌死亡率有显著影响,尤其是在随机分组时年龄为50 - 69岁的女性中。传统上,乳腺癌死亡率是通过对死亡原因进行判断来研究的,这些判断要么来自死亡原因登记册,要么来自医疗记录。在本研究中,采用了另一种方法,即估算与乳腺癌相关的超额死亡率。
1990年,瑞典北部的两个县开始对40 - 74岁的女性进行基于人群的乳腺钼靶筛查。同一地区另外两个县未接受筛查的人群被选为对照。
筛查人群中与乳腺癌相关的超额死亡率较低,且在筛查开始三到四年后即可显现。基于1990 - 1995年期间40 - 74岁(在诊断乳腺癌时)的筛查人群与对照人群中乳腺癌累积超额死亡人数得出的相对风险估计值为0.72(95%置信区间(CI)为0.53至0.99)。对于50 - 69岁的女性,该值为0.67(95% CI为0.46至0.99)。在50 - 69岁年龄组中,1995年筛查县中估计的乳腺癌超额死亡人数为每10万名女性17.0人(95% CI为5.0至29.0),未筛查县为每10万名女性51.1人(95% CI为30.2至71.9)。
基于人群的常规筛查对50 - 69岁女性的乳腺癌死亡率有重大影响。未来研究中可使用超额死亡率估计来评估乳腺钼靶筛查对乳腺癌死亡率的影响。